- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/738 - Cross-linked polysaccharides
Patent holdings for IPC class A61K 31/738
Total number of patents in this class: 180
10-year publication summary
|
17
|
17
|
15
|
10
|
14
|
14
|
11
|
6
|
10
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gelesis LLC | 27 |
10 |
| Seikagaku Corporation | 183 |
10 |
| Galectin Therapeutics Inc. | 37 |
8 |
| Howard University | 191 |
8 |
| Laboratoires Vivacy | 72 |
7 |
| MERZ PHARMA GmbH & CO. KGaA | 609 |
6 |
| Board of Regents, The University of Texas System | 5891 |
5 |
| Xin Ji | 8 |
5 |
| Biotissue Holdings Inc. | 82 |
5 |
| Qmark Medical Inc. | 5 |
4 |
| Anteis SA | 90 |
3 |
| Ben-Gurion University of the Negev Research and Development Authority | 198 |
3 |
| Fidia Farmaceutici S.p.A. | 654 |
3 |
| FrieslandCampina Nederland B.V. | 730 |
3 |
| Hadasit Medical Research Services and Development Ltd. | 305 |
3 |
| InSitu Biologics, Inc. | 17 |
3 |
| Allergan, Inc. | 2329 |
2 |
| Centre National de La Recherche Scientifique | 10595 |
2 |
| The Johns Hopkins University | 5730 |
2 |
| Agency for Science, Technology and Research | 3659 |
2 |
| Other owners | 86 |